April 18, 2023 –Vestibular schwannomas related to neurofibromatosis type 2 (NF2) are difficult to manage and are sometimes treated with a noninvasive option, stereotactic radiosurgery. A retrospective ...

Bevacizumab treatment at 7.5 mg/kg every 3 weeks results in improved hearing in approximately 35%-40% of patients with neurofibromatosis type 2 (NF2) and progressive vestibular schwannomas (VSs).

Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) ...

A vestibular schwannoma is a slow-growing, benign tumor developing in the nerves that connect the inner ear to the brain. These tumors are not malignant, and produce symptoms by pressure on the ...

For patients with NF2-related schwannomatosis and progressive tumors, the ALK inhibitor brigatinib (Alunbrig) was associated with radiographic response for multiple tumor types, as well as ...

A vestibular schwannoma (also known as acoustic neuroma, acoustic neurinoma, or acoustic neurilemoma) is a benign, usually slow-growing tumor that develops from the balance and hearing nerves ...

“In brain surgery, particularly involving the hearing and balance nerve, our approach must be exceedingly refined,” said UVA Health's Jason Sheehan, MD, PhD. “This study shows that Gamma Knife ...

Researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This ...

Because schwannomatosis can be difficult to diagnose, it’s important to know that an accurate diagnosis of the disorder can only be made by a physician with expertise in the diagnosis and treatment of ...